Phase 1Completed

Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions

A Relative Bioavailability Study of 80 mg Pravastatin Sodium Tablets Under Non-Fasting Conditions

Sponsor
Teva Pharmaceuticals USA (Industry)
Enrollment
16 enrolled
Conditions
Healthy
Interventions
Pravastatin; Pravastatin
Ages
adults, older adults
Registry
NCT00829309

Full record on ClinicalTrials.gov

From the registry

This study compared the relative bioavailability (rate and extent of absorption) of Pravastatin Sodium Tablets 80 mg by Teva Pharmaceutical Industries, Ltd. with that of Pravachol® Tablets 80 mg by Bristol-Myers Squibb Company following a single oral dose (1 x 80 mg tablet)in healthy adult male subjects administered under non-fasting conditions.

Primary outcomes

  • Cmax - Maximum Observed Concentration - Pravastatin in Plasma
  • AUC0-inf - Area Under the Concentration-time Curve From Time Zero to Infinity (Extrapolated)
  • AUC0-t - Area Under the Concentration-time Curve From Time Zero to Time of Last Non-zero Concentration (Per Participant)

History

  1. Last registry update

  2. Results first posted

  3. Registered

  4. Started

  5. Primary completion